HCL therapeutic phage manufacturing authorization

An ANSM letter dated May 28, 2026 authorized HCL to manufacture production intermediates and purified therapeutic phage pharmaceutical raw materials under GMP standards. Its PHAGEinLYON programme began in 2017.